Renal effects of a nitric oxide donor, NOC7, in anesthetized rabbits

European Journal of Pharmacology

Volumn 324, Issue 2-3, 1997, Pages 223-226

  Adachi, Yuichiro ^a   Hashimoto, Kazuyuki ^a   Ono, Naoto ^a   Yoshida, Makoto ^a   Suzuki Kusaba, Mizue ^a   Hisa, Hiroaki ^a   Satoh, Susumu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

(Rabbit); Angiotensin II; Kidney; Nitric oxide (NO); NOC 7 (1 hydroxy 2 oxo 3 (N methyl 3 aminopropyl) 3 methyl 1 triazene); Norepinephrine

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; NITRIC OXIDE DONOR; NOC 7; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY TUBULE ABSORPTION; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030988036     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)10009-7     Document Type: Article

References (13)

1. ω-nitro-L-arginine methyl ester and losartan. Eur. J. Pharmacol. 308, 165-171.
2. Bates, J.N., Baker, M.T., Guerra, R.J., Harrison, D.G., 1991. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol. 42, S157-S165.
3. Evans, R.G., Rankin, A.J., Anderson, W.P., 1994. Interactions of blockade of nitric oxide synthase and angiotensin-converting enzyme on renal function in conscious rabbits. J. Cardiovasc. Pharmacol. 24, 542-551.
4. Grandes, S., Gallego, M.J., Riesco, A., López Farré, A., Millas, I., Casado, S., Hernando, L., Caramelo, C., 1991. Mechanisms of renal effects of different agents stimulating production of cGMP. Am. J. Physiol. 261, H1109-H1114.
5. Harris, P.J., Navar, L.G., 1985. Tubular transport responses to angiotensin. Am. J. Physiol. 248, F621-F630.
6. Heuzé-Joubert, I., Mennecier, P., Simonet, S., Laubie, M., Verbeuren, T.J., 1992. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. Eur. J. Pharmacol. 220, 161-171.
7. Hrabie, J.A., Klose, J.R., Wink, D.A., Keefer, L.K., 1993. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 59, 1472-1476.
8. Lahera, V., Navarro, J., Biondi, M.L., Ruilope, L.M., Romero, J.C., 1993. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am. J. Physiol. 264, F344-F347.
9. Majid, D.S., Godfrey, M., Grisham, M.B., Navar, L.G., 1995. Relation between pressure natriuresis and urinary excretion of nitrate/nitrite in anesthetized dogs. Hypertension 25, 860-865.
10. G-nitro-L-arginine, a nitric oxide synthase inhibitor. Biol. Pharm. Bull. 18, 496-500.
11. Salazar, F.J., Pinilla, J.M., López, F., Romero, J.C., Quesada, T., 1992. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 20, 113-117.
12. Stoos, B.S., Garcia, N.H., Garvin, J.G., 1995. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical duct. J. Am. Soc. Nephrol. 6, 89-94.
13. Süto, T., Losonczy, G., Qiu, C., Hill, C., Samsell, L., Ruby, J., Charon, N., Venuto, R., Baylis, C., 1995. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int. 48, 1272-1277.